Russell Investments Group, Ltd. Concert Pharmaceuticals, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$2.69 - $4.22 $115,605 - $181,358	-42,976 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$3.17 - $4.15 $19,647 - $25,721	-6,198 Reduced 12.6%	42,976 $139,000
Q2 2021 Aug 04, 2021	SELL	$3.77 - $5.24 $139,075 - $193,303	-36,890 Reduced 42.86%	49,174 $206,000
Q1 2021 May 10, 2021	SELL	$4.86 - $13.07 $173,706 - $467,147	-35,742 Reduced 29.34%	86,064 $428,000
Q4 2020 Feb 08, 2021	SELL	$9.48 - $12.84 $439,246 - $594,928	-46,334 Reduced 27.56%	121,806 $1.54 Million
Q3 2020 Nov 09, 2020	SELL	$8.67 - $10.82 $28,810 - $35,954	-3,323 Reduced 1.94%	168,140 $1.65 Million
Q2 2020 Aug 05, 2020	BUY	$7.8 - $11.52 $182,598 - $269,683	23,410 Added 15.81%	171,463 $1.7 Million
Q1 2020 May 06, 2020	BUY	$5.98 - $13.09 $407,668 - $892,371	68,172 Added 85.34%	148,053 $1.31 Million
Q4 2019 Jan 29, 2020	SELL	$5.71 - $9.22 $263,927 - $426,166	-46,222 Reduced 36.65%	79,881 $736,000
Q3 2019 Nov 01, 2019	BUY	$5.88 - $12.35 $646,376 - $1.36 Million	109,928 Added 679.62%	126,103 $742,000
Q2 2019 Aug 09, 2019	BUY	$9.44 - $13.12 $152,692 - $212,216	16,175 New	16,175 $194,000
Q1 2019 May 13, 2019	SELL	$12.07 - $17.54 $1.14 Million - $1.66 Million	-94,650 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$11.25 - $16.17 $257,051 - $369,468	-22,849 Reduced 19.45%	94,650 $1.19 Million
Q3 2018 Oct 26, 2018	BUY	$12.82 - $17.88 $508,851 - $709,692	39,692 Added 51.01%	117,499 $1.75 Million
Q2 2018 Aug 08, 2018	SELL	$16.83 - $21.66 $1.46 Million - $1.88 Million	-86,911 Reduced 52.76%	77,807 $1.32 Million
Q1 2018 May 11, 2018	BUY	$19.24 - $28.03 $2.6 Million - $3.79 Million	135,340 Added 460.68%	164,718 $3.77 Million
Q4 2017 Feb 06, 2018	BUY	$13.96 - $29.05 $410,116 - $853,430	29,378	29,378 $760,000

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account